TRIHEXYPHENIDYL
Psychiatric Disorders
University of PittsburghSmall moleculeN/AActive
D
30/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 15/ 100
- Competitive Position
- 95/ 100
Competitive context
2 Active assets in the Psychiatric Disorders cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
Semaglutide St Andrew's Healthcare | Phase 4 | BB |
Opc-34712 Otsuka Pharmaceutical Development & Commercialization, Inc. | Phase 1 | CC |
BENZTROPINE University of Pittsburgh | N/A | D |
Same molecule, other indications
TRIHEXYPHENIDYL is also rated in:
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →